8-KCorporate ChangesExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Bylaw Amendment (Feb 18, 2011)

Filed February 18, 2011For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed a Form 8-K on February 18, 2011, to report an amendment to its Amended and Restated By-laws, effective February 16, 2011. The amendment specifically addresses and codifies the stockholder vote requirements mandated by Sections 14A(a)(1) and 14A(a)(2) of the Securities Exchange Act of 1934. This action ensures the company's compliance with evolving regulatory requirements regarding shareholder votes on executive compensation. For investors, this filing signals that Quest Diagnostics is proactively adhering to regulatory changes impacting corporate governance. While not directly affecting operational performance or financial results, the amendment is a procedural step that strengthens the company's compliance framework. Investors interested in corporate governance and regulatory compliance should note this change as part of their overall assessment of the company's management and operational integrity.

Key Highlights

  • 1Quest Diagnostics amended its By-laws on February 16, 2011.
  • 2The amendment pertains to stockholder vote requirements under Section 14A(a)(1) and 14A(a)(2) of the Securities Exchange Act of 1934.
  • 3This filing ensures compliance with federal regulations regarding shareholder votes.
  • 4The company added new paragraphs (b) and (c) to Section 1.05 of its By-laws.
  • 5The filing is a procedural update related to corporate governance and regulatory adherence.
  • 6No immediate financial or operational impact is indicated by this specific filing.

Frequently Asked Questions

The primary purpose of this 8-K filing is to announce an amendment to Quest Diagnostics' By-laws. This amendment specifically addresses and incorporates the voting requirements for stockholders related to executive compensation, as mandated by Sections 14A(a)(1) and 14A(a)(2) of the Securities Exchange Act of 1934.

Section 14A of the Securities Exchange Act of 1934, introduced by the Dodd-Frank Wall Street Reform and Consumer Protection Act, generally requires public companies to hold non-binding shareholder advisory votes on executive compensation, often referred to as 'say-on-pay'.

This filing is a procedural update related to corporate governance and regulatory compliance. It does not directly alter the company's operations, financial results, or dividend policy, and therefore, is unlikely to have an immediate direct impact on financial performance or stock price. Its significance lies in demonstrating the company's commitment to adhering to regulatory requirements.

The amended and restated By-laws of Quest Diagnostics Incorporated, as amended effective February 16, 2011, are filed as Exhibit 3.1 to this Current Report on Form 8-K and are incorporated by reference.